These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32940662)

  • 1. Epac1 Requires AMPK Phosphorylation to Regulate HMGB1 in the Retinal Vasculature.
    Jiang Y; Steinle JJ
    Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):33. PubMed ID: 32940662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epac1 deacetylates HMGB1 through increased IGFBP-3 and SIRT1 levels in the retinal vasculature.
    Jiang Y; Liu L; Steinle JJ
    Mol Vis; 2018; 24():727-732. PubMed ID: 30581279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound 49b Regulates ZO-1 and Occludin Levels in Human Retinal Endothelial Cells and in Mouse Retinal Vasculature.
    Jiang Y; Liu L; Steinle JJ
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):185-189. PubMed ID: 28114578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epac1 regulates TLR4 signaling in the diabetic retinal vasculature.
    Liu L; Jiang Y; Steinle J
    Cytokine; 2021 Aug; 144():155576. PubMed ID: 34020266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKA regulates HMGB1 through activation of IGFBP-3 and SIRT1 in human retinal endothelial cells cultured in high glucose.
    Liu L; Patel P; Steinle JJ
    Inflamm Res; 2018 Dec; 67(11-12):1013-1019. PubMed ID: 30328477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1
    Jiang Y; Liu L; Curtiss E; Steinle JJ
    Mediators Inflamm; 2017; 2017():2860956. PubMed ID: 28348460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature.
    Liu L; Jiang Y; Steinle JJ
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):14. PubMed ID: 35006270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epac1 and Glycyrrhizin Both Inhibit HMGB1 Levels to Reduce Diabetes-Induced Neuronal and Vascular Damage in the Mouse Retina.
    Liu L; Jiang Y; Steinle JJ
    J Clin Med; 2019 May; 8(6):. PubMed ID: 31159195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice.
    Liu L; Jiang Y; Chahine A; Curtiss E; Steinle JJ
    Mol Vis; 2017; 23():1-7. PubMed ID: 28210097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epac1 Restores Normal Insulin Signaling through a Reduction in Inflammatory Cytokines.
    Curtiss E; Jiang Y; Liu L; Hawthorne C; Zhang J; Steinle JJ
    Mediators Inflamm; 2018; 2018():3809092. PubMed ID: 30116147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
    Jiang S; Chen X
    Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFAIP3 is anti-inflammatory in the retinal vasculature.
    Liu L; Jiang Y; Steinle JJ
    Mol Vis; 2022; 28():124-129. PubMed ID: 36034737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 inhibits insulin signalling through TLR4 and RAGE in human retinal endothelial cells.
    Jiang Y; Steinle JJ
    Growth Factors; 2018 Aug; 36(3-4):164-171. PubMed ID: 31084273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
    Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
    Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
    [No Abstract]   [Full Text] [Related]  

  • 15. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
    Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
    Sohn E; Kim J; Kim CS; Lee YM; Kim JS
    Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy.
    Liang WJ; Yang HW; Liu HN; Qian W; Chen XL
    Life Sci; 2020 Jan; 241():117146. PubMed ID: 31816325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation.
    Kubota S; Ozawa Y; Kurihara T; Sasaki M; Yuki K; Miyake S; Noda K; Ishida S; Tsubota K
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9142-8. PubMed ID: 22058332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt1: A Guardian of the Development of Diabetic Retinopathy.
    Mishra M; Duraisamy AJ; Kowluru RA
    Diabetes; 2018 Apr; 67(4):745-754. PubMed ID: 29311218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis.
    Yu Y; Yang L; Lv J; Huang X; Yi J; Pei C; Shao Y
    Int J Clin Exp Pathol; 2015; 8(6):6807-13. PubMed ID: 26261566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.